Owkin


insights image
04.09.20

Paris-Boston based Owkin, utilizes machine learning for data driven precision medicine, allowing medical researchers to test AI models on distributed data. The company deploys AI and federated learning for medical research and aims to empower researchers in hospitals, universities, and pharmaceutical companies to understand why drug efficacy varies from patient to patient, enhance the drug development process, and identify the best drug for the right patient to improve treatment outcomes.


NEWS

Related Articles

See all